Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

News

  1. Home>
  2. News>
  3. News>
  4. Page 5

Indian Pharma Exports Reach USD 29 Billion in FY26: Generics and Global Demand Drive Growth

  • Post published:May 20, 2026
  • Post category:News

Indian Pharma Exports Reach USD 29 Billion in FY26: Generics and Global Demand Drive Growth India's pharmaceutical export sector continues its strong upward trajectory, clocking approximately USD 29 billion in…

Continue Reading Indian Pharma Exports Reach USD 29 Billion in FY26: Generics and Global Demand Drive Growth

Indian Pharma Exports Surge 18% in Q1 FY2026-27: US ANDA Approvals & Africa Demand Drive Growth

  • Post published:May 18, 2026
  • Post category:News

India's pharmaceutical export sector has recorded an impressive 18% growth in the first quarter of fiscal year 2026-27 (April–June 2026), driven by a surge in US ANDA (Abbreviated New Drug…

Continue Reading Indian Pharma Exports Surge 18% in Q1 FY2026-27: US ANDA Approvals & Africa Demand Drive Growth

Indian Generic Pharma Exports Surge 14% in Q1 2026 as New PLI Scheme Targets 25 Additional API Molecules

  • Post published:May 16, 2026
  • Post category:News

The Indian pharmaceutical export sector has registered a robust 14% year-on-year growth in the first quarter of calendar 2026, reaching USD 8.4 billion, according to the latest data released by…

Continue Reading Indian Generic Pharma Exports Surge 14% in Q1 2026 as New PLI Scheme Targets 25 Additional API Molecules

Pirfenidone for Post-COVID Pulmonary Fibrosis: 2025–2026 Latest Research & Real Result

  • Post published:March 1, 2026
  • Post category:News

New Findings in Pulmonary Fibrosis and Post-COVID Lung Disease Pulmonary fibrosis after COVID-19 is leaving thousands of patients struggling to breathe every day. Many are desperately searching for treatments that…

Continue Reading Pirfenidone for Post-COVID Pulmonary Fibrosis: 2025–2026 Latest Research & Real Result
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Go to the next page

Recent Posts

  • India’s Generic Drug Quality Revolution: Schedule M and CDSCO Audit Guide 2026
    July 3, 2026/
    0 Comments
  • India Pharma Mid-2026: FDA Filings Lead China, API Prices Drop, Biosimilars Rise
    July 2, 2026/
    0 Comments
  • Understanding CDSCO’s Generic Drug Approval Process: A 2026 Guide for Buyers
    July 1, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • India’s Generic Drug Quality Revolution: Schedule M and CDSCO Audit Guide 2026
  • India Pharma Mid-2026: FDA Filings Lead China, API Prices Drop, Biosimilars Rise
  • Understanding CDSCO’s Generic Drug Approval Process: A 2026 Guide for Buyers
  • US-India Trade Deal Very Close: Indian Generics Sector Gains Edge
  • US-India Trade Deal Very Close: Indian Generics Sector Gains Edge

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve